Location History:
- Sandy, UT (US) (2010 - 2013)
- Holladay, UT (US) (2014)
Company Filing History:
2 out of 52 
1 out of 21 
1 out of 11 Years Active: 2010-2014
Title: Innovations and Contributions of Inventor Xiao-Hui Liu
Introduction
Xiao-Hui Liu is a notable inventor based in Sandy, UT (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of protein kinase inhibitors. With a total of 4 patents to her name, her work has implications for cancer treatment and other related conditions.
Latest Patents
Among her latest patents is the invention of imidazo[1,2-B]pyridazine and pyrazolo[1,5-A]pyrimidine derivatives, which serve as protein kinase inhibitors. This invention provides compounds that can be utilized in the treatment of cancer and other Pim kinase-associated conditions. Another significant patent involves pharmaceutical formulations comprising the protein kinase inhibitor MP470, which is aimed at treating conditions characterized by undesirable cell proliferation, such as cancer.
Career Highlights
Xiao-Hui Liu has worked with several prominent companies in the pharmaceutical industry, including Supergen, Inc. and Tolero Pharmaceuticals, Inc. Her expertise in the field has allowed her to contribute to innovative solutions in cancer treatment.
Collaborations
Throughout her career, she has collaborated with notable professionals such as David J Bearss and Hariprasad Vankayalapati. These collaborations have further enhanced her research and development efforts in the pharmaceutical domain.
Conclusion
Xiao-Hui Liu's contributions to the field of pharmaceutical sciences through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in cancer treatment and related therapies.